(Q54522173)

30 May 2018

title

Ketoconazole in griseofulvin-resistant dermatophytosis (English)

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(82)70015-5

14 September 2023

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(82)70015-5

14 September 2023

author name string

M. H. Robertson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6277999

14 September 2023

P. Rich

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6277999

14 September 2023

F. Parker

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6277999

14 September 2023

J. M. Hanifin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6277999

14 September 2023

language of work or name

English

0 references

publication date

1 February 1982

1 reference

30 May 2018

full work available at URL

https://api.elsevier.com/content/article/PII:S0190962282700155?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(82)70015-5

https://api.elsevier.com/content/article/PII:S0190962282700155?httpAccept=text/plain

14 September 2023

1 reference

https://api.crossref.org/works/10.1016/S0190-9622(82)70015-5

Journal of the American Academy of Dermatology

14 September 2023

published in

1 reference

30 May 2018

volume

6

1 reference

30 May 2018

issue

2

1 reference

30 May 2018

page(s)

224-229

1 reference

30 May 2018

An Evaluation of Two Years of Clinical Experience with Ketoconazole

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970015-5

7 January 2021

Experiences in one hundred thirty-seven patients treated with oral griseofulvin. Special reference to clinical recurrences. the healthy carrier state, and their management

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970015-5

7 January 2021

Treatment of Tinea Pedis with Griseofulvin

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970015-5

7 January 2021

Mechanism of action of antifungal drugs, with special reference to the imidazole derivatives.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970015-5

7 January 2021

Griseofulvin and Trichophyton rubrum infections

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970015-5

7 January 2021

Studies Concerning the Development of Resistance to Griseofulvin by Dermatophytes

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970015-5

7 January 2021

Mycological aspects of action of griseofulvin against dermatophytes

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970015-5

7 January 2021

Strategies in the treatment of systemic fungal infections

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970015-5

7 January 2021

Immune responses in patients with chronic Trichophyton rubrum infections

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970015-5

7 January 2021

Oral Therapy with Ketoconazole for Dermatophyte Infections Unresponsive to Griseofulvin

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970015-5

7 January 2021

Treatment of Dermatomycoses with Ketoconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970015-5

7 January 2021

Oral ketoconazole. An effective and safe treatment for dermatophytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970015-5

7 January 2021

The Activity of Ketoconazole in the Treatment of Onychomycosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2882%2970015-5

7 January 2021

Identifiers

1 reference

30 May 2018

1 reference

30 May 2018